2 Stocks to Buy Near Their 52-Week Lows
Thankfully, both companies have plenty of opportunities that could pay off for patient investors. Let's consider why Zoetis and Teladoc are worth buying while they are still hovering near their 52-week lows. Teladoc stock imploded this year as net losses piled up, mainly due to non-cash goodwill impairment charges related to its acquisition of Livongo Health.